l-carnitine tmao koeth 2013 nature medicine Characterization of productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery | Microbiome γ-Butyrobetaine Is a Proatherogenic Intermediate

Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC Dietary Fatty Acids Modulate Gut Microbiota Derived Trimethylamine N Oxide: Potential Mechanisms and Future Perspective Meat metabolizing bacteria in atherosclerosis Nature Medicine Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota PMC Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers

SKU: 79328771636 · From ldesquadrias.com.br